Synergetics Receives FDA Clearance for Versavit Vitrectomy System

Synergetics USA has announced it has received FDA 510(k) for VersaVIT, according to a news release.

 

VersaVIT is a vitrectomy system for the retinal surgery market.



"The entry of VersaVIT into the global vitrectomy market is a major milestone in Synergetics' strategy to enter into higher growth areas of retinal surgery," said David Hable, president and CEO, in the release. "We believe that VersaVIT is a 'game changer' given its functionality, portability and competitive pricing relative to traditional vitrectomy systems."

 

Synergetics USA is headquartered in O'Fallon, Mo.

 

Related Articles on FDA Clearances:

FDA Approves First Glaucoma Stent for Cataract Surgery

Cardinal Health Receives New FDA Clearance for Durablue Sterilization Wrap

InTouch Health Receives FDA 510(k) Clearance for Remote Presence Devices

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers